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1Chapter
The Experimental Bioengineering 
of Complete Spinal Cord Injury in 
Adult Rats
I.N. Bolshakov, A.V. Svetlakov, A.V. Eremeev  
and Yu.I. Sheina
Abstract
The chapter is devoted to the research of experimental complete mechanical spinal 
injury in adult rats and attempts at bioengineering restoration of the structure and 
function of the spinal cord using a protein-polysaccharide construct that includes 
bovine collagen, highly purified crab chitosan ascorbate, nanostructuring additives 
in the form of sodium chondroitin sulfate, sodium hyaluronate, heparin sulfate in the 
presence of complete nutrient medium DMEM, neural supplement N2, conditioned 
nutrient medium, obtained about brain cell mouse embryos and mouse embryonic 
stem cells, retinoic acid, and mouse neural progenitor cells derived from embryonic 
stem cells. After a complete intersection of the spinal cord at the level of the ninth tho-
racic vertebra, the authors directly implanted a collagen-chitosan construct into the 
gap between the ends of the spinal cord. Analysis of the recovery of motor and sen-
sory and vegetative functions of the spinal cord for 20 weeks after surgery using the 
cytological immune-fluorescent method showed a high viability of the transplanted 
neural cell precursors during the entire observation period and the early emergence 
of activity of mediators of nerve signal transmission in the implantation zone of the 
structure with accompaniment active dynamics of reducing neurodeficiency.
Keywords: collagen-chitosan scaffold, complete intersection of the spinal cord,  
mouse neuronal progenitor cells, adult rats, neurological deficiency, 
neurotransmitters, immunofluorescence analysis
1. Introduction
Solid biodegradable constructs as an implant in the spinal cord based on proteins 
and polysaccharides are able to create favorable conditions for the adaptation, 
proliferation, differentiation, and sprouting of the precursors of neural cells placed 
in the implant. At the same time, direct transplantation of the structure together 
with the precursors of neural cells substantially eliminates weight loss during cell 
transfer and the apoptosis reaction and increases the survival time of cells in new 
conditions, and the polysaccharide components of the matrix not only play the 
role of shielding the protein base from the immune system, and also provide a 
high function cell transfer system to the central and peripheral ends of the central 
nervous system. The problem of spinal injury remains acute without addressing 
the issues of effectively eliminating neuro-inflammation in the area of injury and 
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creating conditions for the formation of pathways and sprouting axons under the 
conditions of glial scar formation.
1.1 Embryonic stem cells in the correction of spinal cord injury
A significant improvement of the neurological deficit was achieved by Bottai 
et al. by intravenous administration of undifferentiated ESCs at a dose of 1 mil-
lion cells 2 hours after injury [1]. The protective role of multipotent cells was 
demonstrated during the development of an inflammatory reaction, accompanied 
by a decrease in the intensity of infiltration of the affected area with elements of 
microglia. The presence of hESCs in the spinal cord injury zone in adult rats or 
mini-pigs for 4.5 months induces the formation of embryoid bodies with expres-
sion of specific (hNUMA, HO14, hNSE, and hSYN) and nonspecific (DCX, MAP2, 
CHAT, GFAP, and ACP) antigens. Research results of Yang et al., in a rat spinal cord 
contusion injury model using green fluorescent protein-labeled pig embryonic stem 
cells (pES/GFP (+)), indicate a decrease in expression of green fluorescent protein 
within 3 months, and positively stained cells for neural are detected in the trans-
plant area of specific antigens: anti-NFL, anti-/MBP, anti-SYP, and anti-Tuj 1 [2]. 
The use of undifferentiated cells significantly reduces the efficiency of functional 
restoration of the hind limbs in rats, compared to the use of neural progenitors 
derived from ESCs. The value of indicators of the neurological status on the BBB 
scale was 15.20 ± 1.43 points on the 24th week of the posttransplant period.
1.2 Neural stem cells and their precursors
Under certain conditions, these cells are able to differentiate into neurons, 
astrocytes, and oligodendrocytes. Neuronal progenitors and precursors of oligo-
dendrocytes showed positive dynamics in reducing neuro-deficiency in spinal cord 
injury models. The use of two cell populations with neurogenic and gliogenic activ-
ity leads to the restoration of locomotor functions and stimulates angiogenesis, the 
growth of axons, and their re-myelination [3–11]. A monolayer of neural precur-
sors (NPs) from ESCs is obtained by a combination of diffusion of nutrients and 
growth factors; it includes extracellular matrices such as laminin, poly-d-lysine, and 
matrigel [12]. A three-dimensional matrix with the precursors of neuronal cells or 
oligodendrocytes creates the conditions for the formation of intercellular contacts, 
ensures survival, differentiation, and proliferation [13, 14]. Cultivation of neural 
precursors on a three-dimensional substrate forms oligodendrocyte precursors with 
the expression of Nestin and PAX6 [15, 16]. At the same time, NP cultivation condi-
tions and their micro-environment are of key importance [17].
1.3 Neurotrophic support in the area of spinal cord injury
Re-myelination of damaged axons and improvement of their conductivity are 
possible with transplantations of neural progenitors in the experiment [18, 19]. The 
effect of transplantation is enhanced by trophic support of neurons and immune 
modulation [20–23]. Transplantation of spinal cord precursors of neuronal cells to 
the zone of spinal cord injury is accompanied by activation of axon growth, their 
locomotion, and registration of G-CSF, BDNF, CNTF, FGF, EGF, and NT-3 growth 
factors in cells [24–27]. Consequently, neurotrophic support is a prerequisite for 
the regeneration of specialized nervous tissue when it is lost. The presence of 
neurospheres of exogenous growth factors such as EGF, bFGF, and CNTF in the 
environment creates conditions for the long-term cultivation of viable precursors of 
neurons, differentiation into mature neurons, and successful transfer to the area of 
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spinal injury [28]. Spinal cord regeneration with the help of neural cell progenitors 
indicates the important role of stem cells under conditions of intensive neuro-
trophic support by NGF, BDNF, CNTF, GDNF, and IGF-1 molecules [24, 29].
1.4  Use of degradable biopolymer substrates as implants in the damaged  
spinal cord
Modern technologies for obtaining biomaterials with unique consumer proper-
ties make them the most important link in the task of reconstruction of spinal cord 
injury. Neuroprotection from re-inflammatory response is possible, provided that 
the growth of neurites is artificially oriented with the inclusion of neurotrophic 
support in this system. Studies confirm that the creation of such conditions leads to 
the restoration of lost tissue, enhancement of axonal growth and active sprinting to 
the head and caudal segments of the damaged area, suppression of astrocytosis,  
and the appearance of inter-synaptic connections.
The strategy of reconstruction of the damaged spinal cord includes the use of 
prepared cell mass in solid or liquid, biodegradable, highly compatible 3D matrices 
with favorable conditions for its cultivation, proliferation, and differentiation. Such 
constructions allow direct transfer of cellular material to the area of spinal cord injury.
Matrigel, laminin, type-1-collagen, fibronectin, chitosan, glycosaminoglycans, 
poly-d-lysine, and fibrin are used in experimental practice. The final results of the 
studies do not allow asserting one of the mentioned polymers as the best sample, 
despite the use of combined materials with a neurotrophic microenvironment [30].
The differentiation of hESC in contact with neuronal progenitors occurred more 
actively when laminin was used [31]. In other conditions of cultivation of neuronal 
precursors, the efficiency of using Matrigel is confirmed [32, 33]. A number of 
authors obtained satisfactory results when using a combination of collagen IV, 
laminin, and poly-L-lysine [12, 16, 34]. Such nonstandardized approaches to the 
creation of culture conditions do not exclude the risk of immune reactions.
1.5 Materials based on chitosan to obtain neural substrates
Chitosan, a linear copolymer consisting of N-acetylglucosamine and 
N-glucosamine, when in contact with the wound surface biodegrades without 
causing toxic reactions from surrounding somatic cells and is capable of screening 
protein molecules from the immune system during biodegradation. The number 
of scientific publications on the use of chitosan polymers as the basis of the matrix 
for implantation in the spinal cord in trauma is immeasurably small compared 
to the use of other biopolymers in spinal injury models. The strategy for using 
chitosan polymers for spinal cord reconstruction is developed by Freier et al. [35] 
and Nomura et al. [36]. The advantages of liquid and solid substrates are known for 
cell mass transplantation and neurotrophic support in the spinal cord in trauma. 
However, sponge structures are capable of covering extensive defects in the damage 
zone. An important aspect of the technology is the formation of oriented micro-
channels in the matrix for the directed growth of axons and, thus, enhanced sprout-
ing of cells in the graft area and beyond. The polycationic properties of chitosan 
ensure constant contact of cells with a biopolymer, which enhances cell migration 
and axon regeneration [37] and lengthens and thickens neurites [35], and in low 
concentrations, the biopolymer is able to shield stem and progenitor cells [38].
In 2008, experimental transplantation of neural cell precursors as part of a 
chitosan microchannel biomaterial was performed first after complete transection of 
the spinal cord. The use of NSPS in the spinal cord of Sprague-Dawley rats as a base 
of a highly de-acetylated chitosan hydrochloride micro-channel substrate confirmed 
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that massive cellular transitional bridges containing a high number of differentiated 
cells are formed in the spinal cord within 100 days after the surgical intervention. 
Cell-free channel matrices also formed transition zones, but the thickness of the 
transitions was significantly less [39]. If precultured neural progenitor cells (NSPCs) 
are placed in the micro-channels of the chitosan substrate, in the damaged rat spinal 
cord, one can demonstrate very high cell survival for 5 weeks and their differentia-
tion not only into neurons but also astrocytes and oligodendrocytes [40]. High cell 
survival and differentiation of not only neurons but also glial cells in chitosan extra-
medullary channels and in the spinal cord after transplantation and active sprouting 
from the central to the caudal segment of the spinal cord with the formation of 
active transitional brain tissue are accompanied by significant restoration of the 
motor and sensory functions of the hind limbs [41]. The inflammatory process in the 
area of spinal cord injury stimulates the synthesis of type IV collagen in endothelial 
cells, fibroblasts, and Schwann cells, which leads to the formation of a massive glial 
scar. Productive inflammation in the connective tissue inhibits the growth of axons 
[42–44]. Exogenous suppression of the synthesis of collagen type IV prolongs axonal 
growth. The introduction of type I collagen into the system enhances the growth of 
axons and neural connections between the central and peripheral zone of injury [45, 46].  
It is convincingly shown that the presence of stem cells in the composition of the 
polymer chitosan in the area of spinal cord injury improves cell viability and stimu-
lates their differentiation and the expression of neurotrophic factors. As a result, 
functional neurodeficiency is reduced. Prolonged presence of chitosan in the brain 
tissue and its biodegradation do not stimulate the immune response [47, 48].
Preliminary studies have resulted in 4 variants of the neural matrix that can 
support long-term human ESC and animals (rats) in complete medium and 
translate them into a state of differentiation with reception on the 5th day of cells 
with neuronal markers exposed on its membrane (neuro-filament, MBP, and 
GFAP) [49]. The approaches proposed in this work to the reconstruction of the 
spinal cord in experimental complicated spinal injury (total mechanical spinal 
cord transection) are based on modern biodegradable polysaccharide matrices 
containing the necessary microenvironment, including the products of growth and 
differentiation of stem cells and neuronal cells and neuronal precursor cells for the 
reconstruction of spinal cord to restore its motor and sensory functions. Consumer 
properties of the proposed cellular matrix showed competitive advantages due to 
the lack of matrices satisfying the task. They are as follows: high biocompatibility, 
biodegradability, nontoxicity, the system of information transfer, the creation of a 
strict orientation of the tissues in tissue engineering implant thanks to a rigid linear 
structure of chitosan, the regulation of collagen synthesis, stimulation of breeding 
passaged cell precursor neuronal tissue, vascular endothelial cell proliferation, and 
tumor micro-vessel recovery of the intracellular substrate. Implantation of such a 
matrix can be done in an open manner of the operative spinal cord diastasis.
2. Materials and methods
2.1 Neuronal matrix getting
To create a neural matrix base poly-ion complex consisting of nano-micro-
structured ascorbate chitosan with a molecular weight of 695 kDa and a degree of 
deacetylation of 98%, when the content of 1 g dry chitosan 1.8 g of ascorbic acid, 
comprising anionic salt forms chondroitin acid (Sigma) (20 mg\d), hyaluronic acid 
(Sigma) (10 mg\d) and heparin (5 mg\d) (Russia), serum growth factors in cattle 
“adgelon” (110 mcg\d) were used.
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To obtain the basic collagen-chitosan complex, we used a triply purified chitosan 
obtained in Vostok-Bor-1, Dal’negorsk, Russia with a molecular weight of 695 kDa 
and a deacetylation degree above 95%, protonated with an ascorbic acid solution 
(dissolution of the polymer in ascorbic solution acid in a ratio of 1: 1.5). Introduction 
of a heparin solution, serum low-molecular growth factor “adgelon” (SLL “Endo-
Pharm-A,” Moscow region, Shchyolkovo, Russia), neural supplement N2 (Sigma), 
and retinoic acid (Sigma) stimulated embryonic stem cells (ESCs) in the chitosan 
gel to neuronal differentiation. A conditioned nutrient medium obtained after 
culturing embryonic neuronal cells of brain tissue of mice or conditioned nutrient 
medium obtained after culturing embryonic allogeneic stem cells of mice was added 
to the base poly-ionic complex (Krasnoyarsk Center for Reproductive Medicine, 
Russia). Embryonic stem cells (ESCs) were obtained from mouse blastocysts by 
eluting the uterus with DMEM medium of the anesthetized animal on the 4th–5th 
day after copulation. Getting the inner cell mass (ICM) and the further expansion 
of ESC colonies was performed according to the protocol [50, 51]. Overage human 
blastocysts were taken from patients undergoing IVF. Full consultation was done 
and informed consent was received before embryo processing. This research fol-
lowed the directives of the Russian Association of Human Reproduction. Embryos 
were obtained for research use only, without other restrictions and compensation.
Cultivation of cells was performed in DMEM supplemented with 10% 
fetal calf serum (FCS F0926, Sigma), 100 mg/ml kanamycin sulfate (Sigma), 
1 mM L-glutamine (G7513, Sigma) in bottles Corning, gelatin-coated (Sigma).
In the experiments to obtain the conditioned medium from neural stem embry-
onic mouse cells (cells from the brains of 17–20 day fetus outbred mice (Institute of 
biophyisic SD RAS, Russia) after the dispersion and processing of 0.5% collagenase 
solution (Sigma) for 30 minutes in medium DMEM (Sigma) at 37°C for increasing 
cell biomass used DMEM under light microscopy with 10% fetal calf serum (FCS), 
100 mg/ml canamycin sulfate, 1 mM L-glutamine, which is added 4 ng\ml basic 
fibroblast growth factor (bFGF, Sigma), 1 mM solution of essential amino acids 
(Sigma-Aldrich). The cell biomass was grown at 37°C in vials coated with 0.1% 
gelatin solution. The environment was collected daily. The condition of cells was 
estimated by light microscope. After subculturing with 0.5% collagenase solution, 
the matrix cells were cultured in medium supplemented with neuronal differentia-
tion agent—N2 component, according to the manufacturer’s instructions. The 
medium was collected, filtered through a 0.22 mcm cellulose acetate filter, and used 
hereinafter as a conditioned medium.
Next performed covalent compounds derived polysaccharide gel structure (The 
Developer is SBEU HPT Krasnoyarsk State Medical University, Russia) with bovine 
collagen gel (SLL Belkosin, Russia) in a ratio of 1: 3, a freeze-drying deep frozen sam-
ples to install FC500 (Germany). This mixture was poured on pallets of duralumin, a 
layer thickness of 2 mm, frozen at −20°C, and then freeze-dried at 10−5 Pa for 8 hours; 
the product is packaged and sterilized by the electron beam method (neuronal dry 
matrix courtesy SLL “Medical Company Collachit,” Krasnoyarsk Region, Russia).
The manipulation above yielded a neuronal matrix of the size 50 × 50 × 2 mm, 
suitable for not only the culture and in vitro differentiation of embryonic stem cells 
into neurons and oligodendrocyte progenitor of mice, but also for direct transplan-
tation into the spinal cord gap in experimental injury in adult rats.
When using a sponge matrix, they need to be previously soaked in sterile bicar-
bonate buffer (Sigma) to reduce their acid properties. After neutralization phase of 
collagen-chitosan substrate was washed three times with sterile phosphate-buffered 
Dulbecco’s modified eagle’s medium (Biolot), placed in a vial, and carefully layered 
on top of them the cell suspension in a medium with all the components, depending 
on the cell type.
Translational Studies on Inflammation
6
The cultivation of pluripotent cell experiments on collagen-chitosan 
substrates initially used for biomass growth basal medium DMEM (Sigma) 
supplemented with 10% SR (serum substitute), 100 μg/ml kanamycin sulfate, 
1 mM L-glutamine, 4 ng/ml primary engine of growth fibroblast (bFGF), 1 mM 
solution of amino acids, and the inhibitor Rock 5 ng/ml kinase (Sigma). Capacity 
cell biomass was performed in flasks coated with 0.1% gelatin. The environment 
was changed daily. The colonial state was assessed visually using a microscope 
AxioVert-200. To assess the state of maintenance of pluripotency, limmune-
cytochemical analysis of the expression of markers—oct4, TRA-1-60, SSEA4, and 
cd30 (Sigma)—was performed.
To differentiate embryonic cells in the neuronal direction, they were seeded into 
vials in a medium with all additives except bFGF, with the addition of retinoic acid 
and N2 component.
Every three days, formaldehyde fixation was performed followed by immune-
cytochemistry of the cells with antibodies (Abcam, USA) against GFAP glial fibril-
lar acid protein, neuro-filament, and nestin. Detection of markers was carried out 
by the method according to the instructions of the antibody manufacturer. The cell 
nuclei were stained with DAPI (Sigma) (0.1 μg/ml) for 10 minutes. The Olympus 
BX-51 fluorescence microscope (Japan) and the software products “Applied Spectral 
Imaging” (USA) were used to obtain images and analysis. For the analysis of each 
marker, the experiment was repeated three times, increasing three vials, each of 
which was randomly assigned into 6 zones for carrying out immunocytochemistry. 
Microscopy was carried out for each zone in 30 fields of vision.
2.2 The experimental complete transection of the spinal cord in rats
The conditions of biological test systems in the CDI CI correspond to Guide for 
the Care and Use of Laboratory Animals, 8th edition, 2011, NRC, USA (Manual 
on the content and use of laboratory animals, 8th edition, 2011, national research 
Committee, USA). The content of animals in individually ventilated cells from 
polysulfone seal-safe, 461 × 274 × 228 mm (production TECHNIPLAST.P. A.)
The rooms contain biological test systems, controlled temperature (18–24°C), 
humidity (30–70%), illumination (12/12 hours), and the multiplicity of air (X11 
without recirculation). Control of climatic parameters is carried out in accordance 
with the SOP “control of climatic parameters in the premises of the vivarium.”
Distribution of feed and water is carried out at a fixed time; the change of litter 
is made once a week in accordance with the SOP “preparation of cells for biological 
test systems. Marking. Change of bedding, feed, water.”
Biological test systems receive food “ CHARA” for the maintenance of laboratory 
animals of the SPF-category, production of LLC “Assortment agro” and “VAKA,” 
and production of LLC “BIOSPHERE,” auto-clavable, with confirmation of the 
absence of microbial contamination. The feed is balanced in amino acid composi-
tion, minerals, and vitamins, made of high quality components. Laboratory tests 
for toxicity have been carried out. The food is not toxic, but a environmentally 
friendly product. Certificates of feed quality are present. Sterilization of feed is 
carried out in the steam sterilizer TOUCHCLAVE LAB K14 369 manufactured by 
LTE Scientific LTD, with confirmation of sterilization (multi-parameter chemical 
indicators of sterilization 3 M Comply Steri Gage manufactured by 3 M). After 
sterilization, the feed is stored in closed containers for no more than 7 days (SOP 
“operation of steam sterilizer with automatic control Touchclave-LAB model TC/
R300E/PL/PASS”).
For watering of biological test systems, we used water that had been trained 
in the reverse osmosis production unit JSC “Scientific-production company 
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Mediana-Filter,” confirming the absence of microbial contamination, and bottled in 
pro-anti-cianidinas bottle. Access to food and water is unrestricted throughout the 
study.
The cells consist of a mixture of litter “Golden cat,” produced by “the zone” “the 
Gold Ear,” Russia and “Lignosol,” produced by J. Rettenmaier and Sohne Gmbh, 
Germany, in the ratio of 1:4 subjected to autoclaving, control of microbiological 
purity in accordance with SOP “Operation of a steam sterilizer with automatic 
control Touchclave-LAB model TC/R300E/PL/PASS.”
Veterinary protocol was considered and approved at the meeting of the 
Commission on Bioethics, minutes of the meeting No 57 dated 01.10.2016.
The research methods used in the planned experiment, capable of causing pain 
and stress to animals, cannot be replaced by more humane ones. The possible negative 
effects on animals are minimized and the principles of their humane use are observed.
Premedication: 30 minutes prior to surgery—Sol. Tramadoli 2.5 mg/m; Sol. 
Atropini sulfatis 0.1%–0.1 ml/m; Sol. Dimedroli 0.1%–0.1 ml/m Anesthesia: anes-
thesia (diethyl ether). About 12 white female rats, Wistar line, weighing 250 g with 
Carl Zeiss optics, individually reproduced model of spinal cord injury at the IX-X 
thoracic vertebrae with a complete transverse intersection of the spinal cord after 
first performing a laminectomy.
2.3 Operation course
After preliminary treatment of the operating field with a 70% solution of ethyl 
alcohol under anesthesia, an incision was made along the midline of the animal’s 
back at a level of Th7 to L4 4–5 cm in length. Hemostasis was performed during the 
operation. After dissection of the skin, subcutaneous fat layer, the wound edges 
were mobilized and diluted with Edson’s retractors. The acristoid-trapezius and 
the broadest muscle were cut off from the places of their attachment to the spinous 
processes of Th9-L3. The muscles of the deep layer were separated from the spine 
and diluted with a microsurgical retractor, and the Th9-Th12 vertebrae were bared. 
The Th10 arch resection was performed, and the dura mater was dissected and 
diluted to the sides in the horizontal plane.
A complete transverse intersection of the spinal cord was performed using a 
microscalpel and micro-scissors and individual optics of Carl Zeiss. A neuronal 
cell matrix with a size of about 2 mm3 containing about 100 thousand precursors of 
neuronal cell implant was placed immediately in the formed neural tissue defect. 
The bony wound was closed as a film with polysaccharide hydrogel mass “bolchit” 
[52], which does not contain animal collagen. The wound was closed layer by layer 
using suture material Vicril 4–0 (muscle) and Polyester 3–0 (skin). The stitches 
were treated with an alcohol solution of iodine (Figures 1–6).
Figure 1. 
Quick access to back extensor and awned appendages of vertebras Th VIII-X.
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Figure 3. 
Resection of the ninth chest vertebra handle with removal of a firm brain cover, and spinal cord exposure.
Figure 4. 
Full spinal cord transection.
Figure 2. 
Skeletization of the ninth chest vertebra handle.
Figure 5. 
Cellular neuromatrix implantation of spinal cord diastases.
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2.3.1 The composition of transplantable matrices
On the basis of collagen-chitosan structures, two different implants were 
prepared containing the following components:
1. A lyophilic collagen-chitosan matrix obtained as described above, which does 
not contain cells, including in its composition the complete DMEM nutrient 
medium, conditioned medium from neuronal cells and neural supplement N2, 
and retinoic acid (6 rats of the control group);
2. A lyophilic collagen-chitosan matrix, obtained as indicated above in the 
control group, containing about 100,000 neuronal precursor cells obtained by 
culturing and differentiating mouse embryonic stem cells (ESCm) (6 rats in 
the test group).
Variants of porous matrix substrates were cut into 1 or 2 mm3 before embry-
onic stem cells were placed on them and, in sterile conditions, were unfolded 
in the wells of a 96-well plate without coating with 0.1% gelatin solution. The 
cells from the culture flasks were removed with a 0.5% collagenase solution, 
then washed three times with DMEM medium from the enzyme and transferred 
to wells with a cut matrix in the ESC medium. Cells were cultured for at least 
3 days prior to the appearance of neuronal markers under humid conditions at 
37°C and 6% CO2. The number of attached cells was evaluated by dispersing 5–6 
pieces of the matrix in the enzyme solution, followed by counting the cells in 
the Goryaev chamber. Each future neuron implant during cultivation contained 
about 100 thousand of neuronal precursor cells. Before the implantation in the 
spinal cord, the pieces with a micro pincer were carefully transferred to micro-
tubes with DMEM/F12 culture medium (Nutrient mixture F-12 HAM, Sigma) 
and transported to the operating room.
2.4 Postoperative care
Within 3–5 days after the operation, the animals received Sol as an analgesic; 
Tramadoli 2.5 mg 3 times daily IM. Sutures were removed after 10 days. During 
the first 24 hours, animals were admitted to the water. Feeding was performed 
48 hours after the operation solely with a mixture of “Polyproten-nephro” (SLL 
“Protenpharma,” Russia) for 1–4 weeks. The rats were kept in separate boxes with 
a double bottom. Drug support was provided with a broad-spectrum antibiotic, 
antispasmodics, and vessel-dilator drugs.
Figure 6. 
Restoration of vertebral channel integrity by means of a сhitosan film (it is pointed by an arrow).
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2.5 Dynamic neurological control
To assess the neurological disturbances and recovery dynamics, a scale was 
used to assess the severity of the neurological deficit for complete transection (BBB 
scale) [53] within 20 weeks after implantation.
2.6  The immunofluorescence analysis of sections of the spinal cord after direct 
implantation of cellular neuronal matrices in the dislocation of a spinal 
trauma
Histological sections were subjected to immunofluorescence treatment for the 
search for transplanted cells expressing the green fluorescent protein GFP and the 
presence of neurotransmitters in the upper and lower areas of the spinal cord adja-
cent to the graft, as well as in the collagen chitosan transplant itself: acetylcholine, 
serotonin, and GABA (Abcam, USA). The Olympus BX-51 fluorescence microscope 
and the software products “Applied Spectral Imaging” (USA) were used to obtain 
images and analysis.
Spinal cord preparations obtained by careful and judicious selection of tissue 
from the spinal canal through the 20 weeks after surgery.
3. Results and discussion
Analysis of neurological deficits in rats after complete spinal cord transection 
indicates that transplantation of the cell-free collagen-chitosan matrix into spinal 
cord diastase at the level of thoracic vertebra IX leads to a marked reduction in 
the volume of violations by restoring the function of the pelvic organs in full, and 
provides 5–6 level recovery of motor and sensory functions of the spinal cord 
within 20 weeks of follow-up (Table 1). Implantation into the spinal cord diastasis 
collagen-chitosan substrate of about 100,000 mouse neuronal precursor cells leads 
to virtually eliminate neuronal lack, reaching over 20 weeks 19.5 replacement level 
(Table 1, Figure 7). The serial photo shows the animals in the control and experi-
ment at different times of the postoperative period with different levels of reduc-
tion of neurological deficit (Figures 8–14).
3.1  Immunofluorescent analysis of neurotransmitters in the spinal cord  
sections at its complete transection
Immunofluorescence neurotransmitter control of serial sections of the cerebral 
spinal cord rats 20 weeks after its full transection (the zone above the transplant 
area) shows that the interstitial tissue filled with nuclear cell mass actively express 
GABA, acetylcholine, and serotonin. The number of these cells is the uniformity of 
the distribution center to the area of the graft (Figure 15).
Serial immunofluorescence zone collagen-chitosan graft shows that 20 weeks 
after the operation area is filled with interstitial brain tissue with a large number 
of viable neuronal cells, maternal spinal cord actively expresses markers GABA, 
acetylcholine, and serotonin. Furthermore, zone graft contains many newly formed 
micro-capillaries containing the body of erythrocytes with auto-fluorescence effect. 
The number of nucleated cells in maternal spinal cord transplant decreases  
toward the tail region (Figure 16). In the rear area of the spinal cord (below the 
graft), the number of nucleated cells is substantially less than in the head area and 
in the control graft. However, viable cells express neurotransmitters GABA, acetyl-
choline, and serotonin (Figure 17).
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Lower limb\week 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Neuronal 
lack’s 
level
Experimental 
group (with 
predecessors 
NC)
left 
paw
0 1 2.5 5 7 7 7.5 9 10 11.5 12.5 13 14.5 16 19 19.5 19.5 19.5 19.5 19.5
right 
paw
0 1 1 4 4.5 5.5 7 8.5 10.5 11.5 12.5 13 14.5 16 19 19.5 19.5 19.5 19.5 19.5
Neuronal 
lack’s 
level
The control 
group (without 
predecessor NC
left 
paw
0 0 0.5 1.2 1.8 3.4 4.8 5 5.4 5.4 5.4 5.4 5.4 5.4 5.4 5.4 5.4 5.4 5.4 5.4
right 
paw
0 0.4 0.8 0.8 2.2 4.4 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8 4.8
Table 1. 
Analysis results with complete neurological spinal cord transection and transplantation of collagen-chitosan matrix predecessor mouse neuronal cells (PNCm).
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Figure 9. 
The fourth week after transplantation, level of reduction of neurological deficiency 1 (control).
Figure 7. 
The neurological analysis results of a full transection of a spinal cord. Red (left) and burgundy (right) color 
(experience) back extremities, blue (right) and navy blue (left) color (control) back extremities. Down – levels 
of reduction of neuronal deficiency, across – weeks of supervision.
Figure 8. 
The first week after transplantation, level of reduction of neurological deficiency 0 (control).
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Figure 10. 
The sixth week after transplantation, level of reduction of neurological deficiency 3.9 (control).
Figure 11. 
The eighth week after transplantation, level of reduction of neurological deficiency 4.9 (control).
Figure 12. 
The twentieth week after transplantation, level of reduction of neurological deficiency 5.1 (control).
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Figure 13. 
The eighteenth week after transplantation, level of reduction of neurological deficiency 19.5 (experience).
Figure 14. 
The eighteenth week after transplantation, level of reduction of neurological deficiency 19.5 (experience).
Figure 15. 
The immune fluorescent analysis of serial cut neurotransmitters (from top to down, control): head department 
of a spinal cord in 20 weeks after its full transection (above-transplant zone): GABA (а and b), acetylcholine 
(c–e), and serotonin (f–h).
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Figure 16. 
The immune fluorescent analysis of serial cut neurotransmitters (from top to down, control): zones of a spinal 
cord transplant in 20 weeks after its full transection: GABA (a–g), acetylcholine (h–o), and serotonin (p–y).
Figure 17. 
The immune fluorescent analysis of serial cut neurotransmitters (from top to down, control): a tail zone of a 
spinal cord in 20 weeks after its full transection: GABA (a and b), acetylcholine (c–e), and serotonin (f–h).
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Figure 18. 
The immune fluorescent analysis of serial cut neurotransmitters (from top to down, experience): head 
department of a spinal cord in 20 weeks after its full transection (above-transplant zone): GABA (a and b), 
acetylcholine (c–e), and serotonin (f–h).
Figure 19. 
The immune fluorescent analysis of serial cut neurotransmitters (from top to down, experience) zones collagen-
chitosan of a transplant of a spinal cord in 20 weeks after its full transection: GABA (a–i), acetylcholine (j–r), 
and serotonin (s-a4).
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Research prototypes spinal cord, containing besides the neuronal microenvi-
ronment of growth factors 100,000 neuronal progenitor cells of mice, showed 
that by the transplant register sprouting cells producing GFP, in the area of  the 
central end of the parent spinal cord. Broadcast nucleated cells are accompanied 
by the expression of neurotransmitter GABA, acetylcholine, and serotonin 
(Figure 18). A detailed analysis of the serial sections of the actual donor cells in 
the spinal cord indicates a rich content of viable neurons, producing GFP while 
expressing neurotransmitters. Transplanted cell mass in addition to the par-
ent who came to neuronal cell occupies the entire volume of collagen-chitosan 
scaffold (Figure 19). In the tail of the spinal cord of the experimental group, the 
number of registered nucleated cells with expression and without expression of 
neurotransmitters reduced. The study of serial sections below collagen-chitosan 
cell transplant (tail of the spinal cord) did not reveal the GFP-cell sprouting 
phenomenon (Figure 20).
4. Conclusion
Thus, the results obtained in the course of the studies suggest that the collagen-
chitosan matrix containing the neural progenitor cells is suitable for the repair of 
the damaged cells in the artificial three-dimensional environment. Transplantation 
of acellular collagen-chitosan substrate at full experimental spinal cord transection 
is accompanied by active sprouting maternal cell mass neuronal origin, actively 
expressing markers of neurotransmitters. This change is accompanied by a partial 
recovery of motor, sensory, and autonomic functions of the spinal cord, reaching 
the level of reduction, which is 5.6 point neuronal lack in BBB scale. Transplantation 
of collagen-chitosan matrix containing 100,000 progenitor neuronal cells fol-
lowed for 20 weeks of the maintenance of their viability, in addition to expressing 
neuronal marker mediators of transmission of nerve signals. Transplanted cell mass 
broadcast their axons in the maternal side of the central segment of spinal cord 
beyond the graft. The tail part of the spinal cord after its complete intersection 
demonstrates a reduced number of viable neurons. However, the transplantation of 
a matrix containing precursors of neurons, resulting in significant recovery of lost 
motor and sensory functions of the spinal cord, reaching the level of reduction neu-
ronal lack is equal to 19.5 on a BBB scale. Recent studies show that the inclusion of 
Figure 20. 
The immune fluorescent analysis of serial cut neurotransmitters (from top to down, experience): a tail zone of 
a spinal cord in 20 weeks after its full transection: GABA (a and b), acetylcholine (c–e), and serotonin (f–h).
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implantable structures and aminated polysaccharide polymer in a state of compac-
tion to nanoscale alert direct contact of immune cells with allogeneic or xenogeneic 
cells of nervous tissue that is included in the implant, which substantially reduces 
the immunological conflict in this area of privilege [54–56].
It is known that primary objectives of SCI therapy are processes of neuron 
re-myelination, reduction in apoptosis, damaged neuron and oligodendrocyte 
regeneration, neural cell sprouting, formation of new synaptic connections, reduc-
tion in astrogliosis intensity, neurotrophic support, reduction in leucocytes, and 
macrophage reactions. [57]. Combined therapy of SCI is dictated by complicated 
mechanisms of pathophysiological changes in critical and chronic periods after 
trauma [36, 58–61]. Based on the multifactorial mechanism of spinal trauma the 
main directions of the problem solution of spinal cord bioengineering after its 
damage are formed. The authors of the paper confirm that the cell therapy is an 
attractive therapeutic way of spinal cord function regeneration. The main idea 
formulates the necessary regeneration of deficiency in specialized cells, remaining 
after the injury, which leads to auto-allo-transplantation of exogenic neural stem 
cells (NSCs) and neural precursor cells (NPCs), and stimulation of endogenic 
potential of neural cells. Using optimal neurotrophic support for spinal cord cells 
such as exogenic injections including cocktails from conditioned environments 
and endogenic stimulation is an indispensable component of an integral strategy 
for repairing spinal cord injury. The use of cells as part of biodegrading and highly 
compatible 3D matrix, constituting carcass and benevolent conditions for cultiva-
tion, proliferation, and differentiation of cell material and the possibility of direct 
translation into problematic areas in spinal cord constitute an important part of 
the algorithm in the treatment of spinal cord injury. Biopolymer substrates should 
play the role of protection against permeabilization and progressing destruction of 
neural tissue, and also should regenerate barrier function of damaged membranes.
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